These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 27421765)
1. The safety of intrauterine devices in breastfeeding women: a systematic review. Berry-Bibee EN; Tepper NK; Jatlaoui TC; Whiteman MK; Jamieson DJ; Curtis KM Contraception; 2016 Dec; 94(6):725-738. PubMed ID: 27421765 [TBL] [Abstract][Full Text] [Related]
2. The safety of intrauterine devices among young women: a systematic review. Jatlaoui TC; Riley HEM; Curtis KM Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475 [TBL] [Abstract][Full Text] [Related]
3. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related]
4. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Heinemann K; Reed S; Moehner S; Minh TD Contraception; 2015 Apr; 91(4):274-9. PubMed ID: 25601352 [TBL] [Abstract][Full Text] [Related]
5. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception. Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577 [TBL] [Abstract][Full Text] [Related]
6. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study. Barnett C; Moehner S; Do Minh T; Heinemann K Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):424-428. PubMed ID: 29322856 [TBL] [Abstract][Full Text] [Related]
7. Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study. Kaislasuo J; Suhonen S; Gissler M; Lähteenmäki P; Heikinheimo O Hum Reprod; 2012 Sep; 27(9):2658-63. PubMed ID: 22763376 [TBL] [Abstract][Full Text] [Related]
8. Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study. Bosco-Lévy P; Gouverneur A; Langlade C; Miremont G; Pariente A Contraception; 2019 Jun; 99(6):345-349. PubMed ID: 30871933 [TBL] [Abstract][Full Text] [Related]
9. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls. Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S; Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014 [TBL] [Abstract][Full Text] [Related]
10. Progestin intrauterine devices versus copper intrauterine devices for emergency contraception. Ramanadhan S; Goldstuck N; Henderson JT; Che Y; Cleland K; Dodge LE; Edelman A Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013744. PubMed ID: 36847591 [TBL] [Abstract][Full Text] [Related]
11. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women. Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396 [TBL] [Abstract][Full Text] [Related]
12. Design of the Association of Uterine Perforation and Expulsion of Intrauterine Device study: a multisite retrospective cohort study. Anthony MS; Reed SD; Armstrong MA; Getahun D; Gatz JL; Saltus CW; Zhou X; Schoendorf J; Postlethwaite DA; Raine-Bennett T; Fassett MJ; Peipert JF; Ritchey ME; Ichikawa LE; Lynen R; Alabaster AL; Merchant M; Chiu VY; Shi JM; Xie F; Hui SL; Wang J; Hunter S; Bartsch J; Frenz AK; Chillemi G; Im TM; Takhar HS; Asiimwe A Am J Obstet Gynecol; 2021 Jun; 224(6):599.e1-599.e18. PubMed ID: 33460585 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs. Chi IC Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615 [TBL] [Abstract][Full Text] [Related]
14. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. French R; Van Vliet H; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Helmerhorst F; Guillebaud J Cochrane Database Syst Rev; 2004; 2004(3):CD001776. PubMed ID: 15266453 [TBL] [Abstract][Full Text] [Related]
16. Acceptability of an experimental intracervical device: results of a study controlling for selection bias. Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982 [TBL] [Abstract][Full Text] [Related]
17. Intrauterine device use among women with uterine fibroids: a systematic review. Zapata LB; Whiteman MK; Tepper NK; Jamieson DJ; Marchbanks PA; Curtis KM Contraception; 2010 Jul; 82(1):41-55. PubMed ID: 20682142 [TBL] [Abstract][Full Text] [Related]
18. Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices. Fassett MJ; Reed SD; Rothman KJ; Pisa F; Schoendorf J; Wahdan Y; Peipert JF; Gatz J; Ritchey ME; Armstrong MA; Raine-Bennett T; Postlethwaite D; Getahun D; Shi JM; Xie F; Chiu VY; Im TM; Takhar HS; Wang J; Anthony MS Obstet Gynecol; 2023 Sep; 142(3):641-651. PubMed ID: 37535968 [TBL] [Abstract][Full Text] [Related]
19. Interventions for emergency contraception. Shen J; Che Y; Showell E; Chen K; Cheng L Cochrane Database Syst Rev; 2017 Aug; 8(8):CD001324. PubMed ID: 28766313 [TBL] [Abstract][Full Text] [Related]
20. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women. Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]